Oramed to Present at Ladenburg Thalmann 2019 Healthcare Conference

NEW YORK, Sept. 18, 2019 /PRNewswire/ —  Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, today announced that the company’s Chief Executive Officer, Nadav Kidron, will  present and participate in one-on-one meetings at the 2019 Ladenburg Thalmann Healthcare Conference to be held […]

Join our mailing list

Skip to content